510(k) device
Xtag CF60 Kit V2
Luminex Molecular Diagnostics, Inc. · System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection (NUA, Class II) · First FDA decision Dec 11, 2009, newest Dec 11, 2009Genetic and newborn screening
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Xtag CF60"
MAUDE reports
0
Brand "Xtag CF60", since 2015
PubMed studies
0
Mentioning "Xtag CF60"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Xtag CF60 Kit V2
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- XTAG CF60 KIT V2510(k)
K083845 · Decided Dec 11, 2009 · 352 days after receipt
Device type: System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection (NUA) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Xtag CF60", any status and sponsor, newest update first.
No registered device study names "Xtag CF60".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Xtag CF60", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NUA
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Xtag CF60"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NUA.
- xTAG Cystic Fibrosis 39 Kit v2Luminex Molecular Diagnostics, Inc. · 510(k) 2016
- Tag-It Cystic Fibrosis KitTm Bioscience Corporation · De Novo 2006
- Esensor Cystic Fibrosis Carrier Detection System, Model Esensor 4800Clinical Micro Sensors, Inc. · 510(k) 2006
- Verigene Cftr Nucleic Acid Test and Verigene Cftr Polyt Nucleic Acid TestNanosphere, Inc. · 510(k) 2009
- Esensor Cf Genotyping Testm Esensor SystemOsmetech Molecular Diagnostics · 510(k) 2009
- Inplex Cf Molecular TestThird Wave Technologies, Inc. · 510(k) 2008
- Cystic Fibrosis Genotyping Assay, Model 6L20-01Celera Diagnostics · 510(k) 2007
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.